Medpace Statistics
Share Statistics
Medpace has 31.08M shares outstanding. The number of shares has increased by 1.05% in one year.
| Shares Outstanding | 31.08M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.26% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 25.49M |
| Failed to Deliver (FTD) Shares | 803 |
| FTD / Avg. Volume | 0.24% |
Short Selling Information
The latest short interest is 1.17M, so 3.75% of the outstanding shares have been sold short.
| Short Interest | 1.17M |
| Short % of Shares Out | 3.75% |
| Short % of Float | 4.57% |
| Short Ratio (days to cover) | 3.53 |
Valuation Ratios
The PE ratio is 33.3 and the forward PE ratio is 28.89. Medpace 's PEG ratio is 0.44.
| PE Ratio | 33.3 |
| Forward PE | 28.89 |
| PS Ratio | 4.99 |
| Forward PS | 3.9 |
| PB Ratio | 16.85 |
| P/FCF Ratio | 23.74 |
| PEG Ratio | 0.44 |
Enterprise Valuation
Medpace Inc. has an Enterprise Value (EV) of 9.31B.
| EV / Earnings | 32.93 |
| EV / Sales | 4.94 |
| EV / EBITDA | 25.65 |
| EV / EBIT | 27.65 |
| EV / FCF | 23.48 |
Financial Position
The company has a current ratio of 0.64, with a Debt / Equity ratio of 0.
| Current Ratio | 0.64 |
| Quick Ratio | 0.64 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 690.22 |
Financial Efficiency
Return on equity (ROE) is 0.51% and return on capital (ROIC) is 40.48%.
| Return on Equity (ROE) | 0.51% |
| Return on Assets (ROA) | 0.17% |
| Return on Capital (ROIC) | 40.48% |
| Revenue Per Employee | 319.63K |
| Profits Per Employee | 47.93K |
| Employee Count | 5.90K |
| Asset Turnover | 1.14 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 52.87M |
| Effective Tax Rate | 0.16 |
Stock Price Statistics
The stock price has increased by 12.33% in the last 52 weeks. The beta is 1.37, so Medpace 's price volatility has been higher than the market average.
| Beta | 1.37 |
| 52-Week Price Change | 12.33% |
| 50-Day Moving Average | 338.07 |
| 200-Day Moving Average | 372.09 |
| Relative Strength Index (RSI) | 52.09 |
| Average Volume (20 Days) | 330.67K |
Income Statement
In the last 12 months, Medpace had revenue of 1.89B and earned 282.81M in profits. Earnings per share was 9.2.
| Revenue | 1.89B |
| Gross Profit | 524.50M |
| Operating Income | 336.82M |
| Net Income | 282.81M |
| EBITDA | 363.15M |
| EBIT | 336.82M |
| Earnings Per Share (EPS) | 9.2 |
Balance Sheet
The company has 245.45M in cash and 142.12M in debt, giving a net cash position of 103.33M.
| Cash & Cash Equivalents | 245.45M |
| Total Debt | 142.12M |
| Net Cash | 103.33M |
| Retained Earnings | -221.65M |
| Total Assets | 2.08B |
| Working Capital | -8.76M |
Cash Flow
In the last 12 months, operating cash flow was 433.37M and capital expenditures -36.65M, giving a free cash flow of 396.73M.
| Operating Cash Flow | 433.37M |
| Capital Expenditures | -36.65M |
| Free Cash Flow | 396.73M |
| FCF Per Share | 12.91 |
Margins
Gross margin is 2.78K%, with operating and profit margins of 1.79K% and 1.50K%.
| Gross Margin | 2.78K% |
| Operating Margin | 1.79K% |
| Pretax Margin | 1.78K% |
| Profit Margin | 1.50K% |
| EBITDA Margin | 19.26% |
| EBIT Margin | 17.86% |
| FCF Margin | 21.04% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 2.69% |
| FCF Yield | 3.74% |
Analyst Forecast
The average price target for MEDP is $363, which is 6.2% higher than the current price. The consensus rating is "Hold".
| Price Target | $363 |
| Price Target Difference | 6.2% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
Scores
| Altman Z-Score | 7 |
| Piotroski F-Score | 6 |